Daiichi Sankyo is a global pharmaceutical company based in Japan that has a presence in more than 20 countries around the world. With a rich legacy of over 100 years of scientific expertise, we are the pioneer behind leading pharmaceuticals that have contributed to the improvement of countless lives.
www.daiichi-sankyo.eu AMOUNT: 50.000 Euros
Daiichi Sankyo supports the Cardio Update Europe 2020 as Gold Partner.
Vifor Pharma Group’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.
www.viforpharma.com AMOUNT: 33.000 Euros
Vifor Pharma supports the Cardio Update Europe 2020 as Gold Partner.
Medtronic is the global leader medical technology, alleviating pain, restoring health an extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies - every three seconds, another life is improved by a Medtronic product or therapy.
www.medtronic.com AMOUNT: 17.500 Euros
Medtronic supports the Cardio Update Europe 2020 as Silver Partner.
At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. OUR FOCUS articulates who we are and what we strive for, how we work and what we want to achieve.
www.boehringer-ingelheim.com AMOUNT: 10.000 Euros
Boehringer Ingelheim supports the Cardio Update Europe 2020 as Partner.
Servier is committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to transmit to future generations a world that can ensure access to quality health care for all.
www.servier.com AMOUNT: 10.000 Euros
Servier supports the Cardio Update Europe 2020 as Partner.
